GE Aerospace (GE)

Investing Cash Flow

-$2.79B

TTM · Period ending: · USD

GE logo

GE Investing Cash Flow

Latest reported-$2.79B
GE TTM Cash from Investing (-$15.91B → -$2.79B)
High-resolution chart · PNG

GE investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

GE Aerospace Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-2,788,000,000
-2,274,000,000
-1,755,000,000
-1,153,000,000
-1,137,000,000
960,000,000
-2,791,000,000
-1,666,000,000
-303,000,000
659,000,000
6,570,000,000
3,966,000,000
2,960,000,000
574,000,000
918,000,000
2,270,000,000
22,674,000,000
22,939,000,000
20,662,000,000
21,308,000,000
-811,000,000
-1,883,000,000
-2,242,000,000
16,642,000,000
21,568,000,000
23,976,000,000
24,535,000,000
8,939,000,000
11,694,000,000
16,225,000,000
22,336,000,000
18,280,000,000
15,456,000,000
9,692,000,000
3,289,000,000
6,564,000,000
10,443,000,000
19,743,000,000
20,128,000,000
49,202,000,000
41,220,000,000
74,709,000,000
87,431,000,000
59,487,000,000
56,659,000,000
11,634,000,000
-2,983,000,000
-5,030,000,000
-4,824,000,000
-7,946,000,000
-576,000,000
29,117,000,000
30,789,000,000
43,609,000,000
37,468,000,000
11,302,000,000
10,000,000,000
3,746,000,000
7,916,000,000
19,882,000,000
20,313,000,000
25,476,000,000
30,712,000,000
32,436,000,000
42,729,000,000
43,582,000,000
46,110,000,000
42,997,000,000
46,041,000,000
26,705,000,000
-3,367,000,000
-40,901,000,000
-82,129,000,000
-82,863,000,000
-86,887,000,000
-72,424,000,000
-58,937,000,000
-62,002,000,000
-52,214,000,000
-51,402,000,000
-48,224,000,000
-46,454,000,000
-33,318,000,000
-35,049,000,000
-34,102,000,000
-27,462,000,000
-36,712,000,000
-38,414,000,000
-32,934,000,000
-16,680,000,000
-28,237,000,000
-22,903,000,000
-38,381,000,000
-59,362,000,000
-57,332,000,000
-61,949,000,000
-58,253,000,000
-55,502,000,000
-46,739,000,000
-40,114,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.